Dexmedetomidine-induced contraction involves phosphorylation of caldesmon by JNK in endotheliumdenuded rat aortas

International Journal of Biological Sciences

Volumn 10, Issue 10, 2014, Pages 1108-1115

  Baik, Jiseok ^a   Ok, Seong Ho ^b   Cho, Hyunhoo ^c   Yu, Jongsun ^c   Kim, Woochan ^c   Nam, In Koo ^c   Choi, Mun Jeoung ^c   Lee, Heon Keun ^b   Sohn, Ju Tae ^b  

^a Pusan National University School of Medicine   (South Korea)

^b Gyeongsang National University School of Medicine   (South Korea)

^c Gyeongsang National University   (South Korea)

Author keywords

Alpha 2 adrenoceptor; c Jun NH2 terminal kinase; Caldesmon; Contraction; Dexmedetomidine; Protein kinase C; Rat aorta

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; BENZOPHENANTHRIDINE DERIVATIVE; CALMODULIN BINDING PROTEIN; CHELERYTHRINE; DEXMEDETOMIDINE; PROTEIN KINASE C; YOHIMBINE;

ANALYSIS OF VARIANCE; ANIMAL; AORTA; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; MUSCLE CONTRACTION; PHOSPHORYLATION; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; ANTHRACENES; AORTA; BENZOPHENANTHRIDINES; BLOTTING, WESTERN; CALMODULIN-BINDING PROTEINS; CELLS, CULTURED; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RECEPTORS, ADRENERGIC, ALPHA-2; SIGNAL TRANSDUCTION; YOHIMBINE;

EID: 84907876618     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.9797     Document Type: Article

References (26)

1. Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: a novel sedative-analgesic agent. Proc (BaylUniv Med Cent) 2001; 14:13-21.
2. Peltonen JM, Pihlavisto M, Scheinin M. Subtype-specific stimulation of[35S]GTPgammaS binding by recombinant alpha2-adrenoceptors. Eur J Pharmacol 1998; 355:275-279.
3. Guimarães S, Moura D. Vascular adrenoceptors: an update. Pharmacol Rev 2001; 53:319-356.
4. Schmeling WT, Kampine JP, Roerig DL, Warltier DC. The effects of the stereoisomers of the alpha 2-adrenergic agonist medetomidine on systemic and coronary hemodynamics in conscious dogs. Anesthesiology 1991; 75:499-511.
5. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000; 90:699-705.
6. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 1992; 77:1134-1142.
7. Erkonen G, Lamb F, Tobias JD. High-dose dexmedetomidine-induced hypertension in a child with traumatic brain injury. Neurocrit Care 2008; 9:366-369.
8. Mason KP, Zurakowski D, Zgleszewski S, Prescilla R, Fontaine PJ, Dinardo JA. Incidence and predictors of hypertension during high-dose dexmedetomidine sedation for pediatric MRI. Paediatr Anaesth 2010; 20:516-523.
9. Shah S, Sangari T, Qasim M, Martin T. Severe hypertension and bradycardia after dexmedetomidine for radiology sedation in a patient with acute transverse myelitis. Paediatr Anaesth 2008; 18:681-682.
10. Ok SH, Jeong YS, Kim JG, Lee SM, Sung HJ, Kim HJ, Chang KC, Kwon SC, Sohn JT. c-Jun NH2-terminal kinase contributes to dexmedetomidine-induced contraction in isolated rat aortic smooth muscle. Yonsei Med J 2011; 52:420-428.
11. Kim JG, Sung HJ, Ok SH, Kwon SC, Cheon KS, Kim HJ, Chang KC, Shin IW, Lee HK, Chung YK, Sohn JT. Calcium sensitization involved in dexmedetomidine-induced contraction of isolated rat aorta. Can J Physiol Pharmacol 2011; 89:681-689.
12. Yamaguchi H, Igarashi M, Hirata A, Sugae N, Tsuchiya H, Jimbu Y, Tominaga M, Kato T. Altered PDGF-BB-induced p38 MAP kinase activation in diabetic vascular smooth muscle cells: roles of protein kinase C-delta. Arterioscler Thromb Vasc Biol 2004; 24:2095-2101.
13. Ginnan R, Singer HA. PKC-delta-dependent pathways contribute to PDGF-stimulated ERK1/2 activation in vascular smooth muscle. Am J Physiol Cell Physiol 2005; 288:C1193-C1201.
14. Kim HR, Appel S, Vetterkind S, Gangopadhyay SS, Morgan KG. Smooth muscle signalling pathways in health and disease. J Cell Mol Med 2008; 12:2165-2180.
15. Akata T. General anesthetics and vascular smooth muscle: direct actions of general anesthetics on cellular mechanisms regulating vascular tone. Anesthesiology 2007; 106:365-391.
16. Ok SH, Kwon SC, Yeol Han J, Yu J, Shin IW, Lee HK, Chung YK, Choi MJ, Sohn JT. Mepivacaine-induced contraction involves increased calcium sensitization mediated via Rho kinase and protein kinase C in endothelium-denuded rat aorta. Eur J Pharmacol 2014; 723:185-193.
17. Ok SH, Bae SI, Shim HS, Sohn JT. Dexmedetomidine-induced contraction of isolated rat aorta is dependent on extracellular calcium concentration. Korean J Anesthesiol 2012; 63:253-259.
18. Kim HJ, Sohn JT, Jeong YS, Cho MS, Kim HJ, Chang KC, Shin MK, Park CS, Chung YK. Direct effect of dexmedetomidine on rat isolated aorta involves endothelial nitric oxide synthesis and activation of the lipoxygenase pathway. Clin Exp Pharmacol Physiol 2009; 36:406-412.
19. Jin L, Teixeira CE, Webb RC, Leite R. Comparison of the involvement of protein kinase C in agonist-induced contractions in mouse aorta and corpus cavernosum. Eur J Pharmacol 2008; 590:363-368.
20. Lee HM, Ok SH, Sung HJ, Eun SY, Kim HJ, Lee SH, Kang S, Shin IW, Lee HK, Chung YK, Choi MJ, Bae SI, Sohn JT. Mepivacaine-induced contraction involves phosphorylation of extracellular signal-regulated kinase through activation of the lipoxygenase pathway in isolated rat aortic smooth muscle. Can J Physiol Pharmacol 2013; 91:285-294.
21. Horiuchi KY, Miyata H, Chacko S. Modulation of smooth muscle actomyosin ATPase by thin filament associated proteins. Biochem Biophys Res Commun 1986; 136:962-968.
22. Adam LP, Hathaway DR. Identification of mitogen-activated protein kinase phosphorylation sequences in mammalian h-Caldesmon. FEBS Lett 1993; 322:56-60.
23. Kordowska J, Huang R, Wang CL. Phosphorylation of caldesmon during smooth muscle contraction and cell migration or proliferation. J Biomed Sci 2006; 13:159-172.
24. Shafaroudi MM, McBride M, Deighan C, Wokoma A, Macmillan J, Daly CJ, McGrath JC. Two "knockout" mouse models demonstrate that aortic vasodilatation is mediated via alpha2a-adrenoceptors located on the endothelium. J Pharmacol Exp Ther 2005; 314:804-810.
25. Christensen KL, Mulvany MJ. Location of resistance arteries. J Vasc Res 2001; 38:1-12.
26. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93:382-394.